Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. МА_Serbia_2023_espi_26.pdf Analysis of potential acquisition opportunities on the territory of the Republic of Serbia

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 26 / 2023
Date of issue: 2023-06-01
Short name of the issuer
SOPHARMA AD
Subject
Analysis of potential acquisition opportunities on the territory of the Republic of Serbia
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
“Sopharma” AD (the Company) notifies that at its meeting the Board of Directors decided to conduct a detailed analysis of potential opportunities for acquisition of shares in the capital of companies engaged in the production and/or marketing of medicinal products, food supplements, medical devices and/or other goods of importance to human health on the territory of the Republic of Serbia. The Board of Directors has authorized the representatives of the Company to carry out all necessary legal and factual actions related to the evaluation, investigation and initial negotiations for the implementation of a possible acquisition of a joint participation and/or a majority stake in the capital of such companies.
Annexes
File Description
МА_Serbia_2023_espi_26.pdf
МА_Serbia_2023_espi_26.pdf		 Analysis of potential acquisition opportunities on the territory of the Republic of Serbia

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2023-06-01 Ognian Donev Executive Director
20230601_134515_0228018279_MA_Serbia_2023_espi_26.pdf

Pobierz